AR032440A1 - Metodo para reducir o eliminar el tabaquismo - Google Patents
Metodo para reducir o eliminar el tabaquismoInfo
- Publication number
- AR032440A1 AR032440A1 ARP010100637A ARP010100637A AR032440A1 AR 032440 A1 AR032440 A1 AR 032440A1 AR P010100637 A ARP010100637 A AR P010100637A AR P010100637 A ARP010100637 A AR P010100637A AR 032440 A1 AR032440 A1 AR 032440A1
- Authority
- AR
- Argentina
- Prior art keywords
- nicotine
- tobacco
- alternative source
- habit
- tobacco use
- Prior art date
Links
- 241000208125 Nicotiana Species 0.000 title abstract 10
- 235000002637 Nicotiana tabacum Nutrition 0.000 title abstract 10
- 238000000034 method Methods 0.000 title abstract 3
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical group CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract 9
- 229960002715 nicotine Drugs 0.000 abstract 9
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract 9
- 230000000391 smoking effect Effects 0.000 abstract 2
- 230000002618 waking effect Effects 0.000 abstract 2
- 206010057852 Nicotine dependence Diseases 0.000 abstract 1
- 208000025569 Tobacco Use disease Diseases 0.000 abstract 1
- 230000003542 behavioural effect Effects 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacture Of Tobacco Products (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/504,560 US6660754B1 (en) | 2000-02-15 | 2000-02-15 | Method for reducing or eliminating smoking |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR032440A1 true AR032440A1 (es) | 2003-11-12 |
Family
ID=24006789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010100637A AR032440A1 (es) | 2000-02-15 | 2001-02-13 | Metodo para reducir o eliminar el tabaquismo |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6660754B1 (https=) |
| EP (1) | EP1265610A4 (https=) |
| JP (1) | JP2003522789A (https=) |
| KR (1) | KR20020075795A (https=) |
| CN (1) | CN1400901A (https=) |
| AR (1) | AR032440A1 (https=) |
| AU (1) | AU782403B2 (https=) |
| BR (1) | BR0108318A (https=) |
| CA (1) | CA2400353A1 (https=) |
| CO (1) | CO5261581A1 (https=) |
| CZ (1) | CZ20022766A3 (https=) |
| EA (1) | EA004184B1 (https=) |
| EG (1) | EG22199A (https=) |
| HU (1) | HUP0301131A3 (https=) |
| MY (1) | MY127259A (https=) |
| NZ (1) | NZ520586A (https=) |
| PE (1) | PE20011221A1 (https=) |
| PL (1) | PL357013A1 (https=) |
| WO (1) | WO2001060364A1 (https=) |
| ZA (1) | ZA200207217B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050112148A1 (en) * | 2003-11-21 | 2005-05-26 | Dmitruk Victor M. | Habit based self-help method for smoking cessation |
| US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
| US20080230078A1 (en) * | 2007-03-19 | 2008-09-25 | Oby George Tolman | Method of smoking cessation |
| EP2515918B1 (en) * | 2009-12-21 | 2014-10-08 | RCP Development, Inc. | Smoking cessation lozenge containing tobacco alkaloid and silver salt |
| US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
| US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
| CN101858902B (zh) * | 2010-06-01 | 2012-12-12 | 中国科学院广州地球化学研究所 | 一种结合碳同位素比值的土壤蚀变碳酸盐的测量方法 |
| US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
| US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
| US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
| US20140255452A1 (en) | 2013-03-11 | 2014-09-11 | Niconovum Usa, Inc. | Method and apparatus for differentiating oral pouch products |
| US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
| CN108685184B (zh) * | 2017-04-11 | 2020-06-16 | 常州市派腾电子技术服务有限公司 | 辅助戒烟方法及辅助戒烟装置 |
| CN107149028A (zh) * | 2017-04-17 | 2017-09-12 | 廖华勇 | 内含微量烟草气味的香口胶 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5055478A (en) | 1986-06-19 | 1991-10-08 | Cooper Thomas M | Method for stopping smoking |
| US5488962A (en) | 1990-10-10 | 1996-02-06 | Perfetti, S.P.A. | Chewing gum which is a substitute for tobacco smoke |
| AR030092A1 (es) * | 2000-08-02 | 2003-08-13 | Smithkline Beecham Corp | Metodo para reducir o eliminar el fumar |
-
2000
- 2000-02-15 US US09/504,560 patent/US6660754B1/en not_active Expired - Lifetime
-
2001
- 2001-02-13 AR ARP010100637A patent/AR032440A1/es unknown
- 2001-02-13 MY MYPI20010641A patent/MY127259A/en unknown
- 2001-02-13 PE PE2001000154A patent/PE20011221A1/es not_active Application Discontinuation
- 2001-02-14 EG EG20010130A patent/EG22199A/xx active
- 2001-02-14 CO CO01011530A patent/CO5261581A1/es not_active Application Discontinuation
- 2001-02-15 EP EP01910708A patent/EP1265610A4/en not_active Withdrawn
- 2001-02-15 KR KR1020027010559A patent/KR20020075795A/ko not_active Withdrawn
- 2001-02-15 CA CA002400353A patent/CA2400353A1/en not_active Abandoned
- 2001-02-15 HU HU0301131A patent/HUP0301131A3/hu unknown
- 2001-02-15 BR BR0108318-0A patent/BR0108318A/pt not_active Application Discontinuation
- 2001-02-15 CN CN01804937A patent/CN1400901A/zh active Pending
- 2001-02-15 EA EA200200765A patent/EA004184B1/ru not_active IP Right Cessation
- 2001-02-15 CZ CZ20022766A patent/CZ20022766A3/cs unknown
- 2001-02-15 AU AU38289/01A patent/AU782403B2/en not_active Expired
- 2001-02-15 PL PL01357013A patent/PL357013A1/xx not_active Application Discontinuation
- 2001-02-15 WO PCT/US2001/004798 patent/WO2001060364A1/en not_active Ceased
- 2001-02-15 JP JP2001559461A patent/JP2003522789A/ja not_active Withdrawn
- 2001-02-15 NZ NZ520586A patent/NZ520586A/en not_active IP Right Cessation
-
2002
- 2002-09-09 ZA ZA200207217A patent/ZA200207217B/en unknown
-
2003
- 2003-09-24 US US10/670,922 patent/US20040058966A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EA004184B1 (ru) | 2004-02-26 |
| AU3828901A (en) | 2001-08-27 |
| BR0108318A (pt) | 2003-02-18 |
| US20040058966A1 (en) | 2004-03-25 |
| MY127259A (en) | 2006-11-30 |
| KR20020075795A (ko) | 2002-10-05 |
| ZA200207217B (en) | 2003-08-04 |
| US6660754B1 (en) | 2003-12-09 |
| CA2400353A1 (en) | 2001-08-23 |
| CO5261581A1 (es) | 2003-03-31 |
| NZ520586A (en) | 2004-11-26 |
| PL357013A1 (en) | 2004-07-12 |
| CZ20022766A3 (cs) | 2003-05-14 |
| HUP0301131A3 (en) | 2004-01-28 |
| JP2003522789A (ja) | 2003-07-29 |
| HUP0301131A2 (hu) | 2003-08-28 |
| EA200200765A1 (ru) | 2003-02-27 |
| CN1400901A (zh) | 2003-03-05 |
| EP1265610A1 (en) | 2002-12-18 |
| WO2001060364A1 (en) | 2001-08-23 |
| EP1265610A4 (en) | 2008-04-02 |
| AU782403B2 (en) | 2005-07-28 |
| PE20011221A1 (es) | 2002-02-07 |
| EG22199A (en) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032440A1 (es) | Metodo para reducir o eliminar el tabaquismo | |
| AR039947A1 (es) | Formulacion farmaceutica que comprende nicotina | |
| AR041725A1 (es) | Prevencion, tratamiento de la enfermedad sinucleinopatica y composicion farmacologica | |
| Mackenzie | The Physiological and Pathological Relations between the Nose and the Sexual Apparatus of Man1 | |
| US5055478A (en) | Method for stopping smoking | |
| MX9207402A (es) | Dispositivo osmotico para surtir un agente benefico a la cavidad oral. | |
| TR200001891T2 (tr) | ASPB28- İnsan ensülini ve kullanımı. | |
| AR033444A1 (es) | Forma solida de dosificacion util para la administracion oral de un compuesto activo de nicotina, a traves de la mucosa y uso de un compuesto activo de nicotina para prepararla | |
| ATE388687T1 (de) | Medikamentöse verabreichung von nikotin in form von kaugummi | |
| ES2186693T3 (es) | Uso combinado del acido hialuronico y de agentes terapeuticos para mejorar el efecto terapeutico. | |
| ES2135460T3 (es) | Composicion para ayudar a dejar de fumar. | |
| DE60022021D1 (de) | Zubereitungen enthaltend Apomorphin und Sildenafil und ihre Verwendung zur Behandlung von erektiler Dysfunktion | |
| AR022090A1 (es) | PARTíCULAS PARA LA ADMINISTRACIoN DE UN AGENTE ACTIVO A LOS ALVÉOLOS DE UN PACIENTE HUMANO, UN MÉTODO PARA SU PREPARACIoN, Y EL USO DE LAS MISMAS PARA LA PREPARACIoN DE UN MEDICAMENTO PARA INHALACIoN | |
| AR020803A1 (es) | Una composicion que comprende fexofenadina o una sal farmaceuticamente aceptable de la misma y el uso de la misma para la manufactura de unmedicamento | |
| EE200200565A (et) | Vaskulaarse kahjustava toimega kombinatsioonravi | |
| CY1107500T1 (el) | Η χρηση του φλουμαζενιλ στην αναπτυξη ενος φαρμακου για τη θepαπευτικη αντιμετωπιση της εξαρτησης απο το αλκοολ | |
| JP2003522789A5 (https=) | ||
| BRPI0409699A (pt) | métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos | |
| BR0313503A (pt) | Método de tratamento de sìndrome das pernas inquietas, uso do antagonista de receptor da adenoina a2a, agente terapêutico para sìndrome das pernas inquietas, e, método de tratamento da mioclonia noturna | |
| AR027287A1 (es) | Gonadotrofina | |
| JP2000178203A5 (https=) | ||
| Whale et al. | Does mirtazapine enhance serotonergic neurotransmission in depressed patients? | |
| Mugnoor et al. | Role of Triphladi Taila Matra Basti in Parikartika: A Single Case Study | |
| US20060029648A1 (en) | Stimulant/desensitizer swabs | |
| Baliga | Smart pediatric dentistry: We have come a long way! |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |